The US, Canada, and Mexico are major economies in North America. There has been a constant increase in organ failure incidence across the region, owing to various chronic health conditions such as cardiovascular disorders, genetic conditions, and diabetes. As per Health Resources and Service Administration report 2020, 106,247 people, including men, women, and children, are on the national transplant waiting list. Every 9 minutes, another person is added to the transplant list in the US. Thus, the rising incidence of organ failure has created the demand for organ transplant procedures, which, in turn, is driving the organ care products market.
Over the period, there has been a significant increase in organ donation, owing to a rise in awareness among people and rapidly developing health facilities. According to the Health Resources and Service Administration report 2020, 22,817 kidney transplantations have been performed in the US, accounting for 83% of the total transplant procedures in the US. Furthermore, development in healthcare facilities to enhance the success rates of transplant procedures and reduce organ rejection rates has increased the organ transplantation procedures, fueling the demand for organ care products and contributing to the growth of organ care products markets
On the other hand, timing, storage, and transportation have an important role in transplant procedures, especially in the case of circulatory death. Timely removal of organs, transportation, and implantation are expected to increase the success rates; this requires efficient organ care products to keep the organ safe until implantation. For this purpose, several market players such as TransMedics and OrganOx Limited have designed various systems with advanced technology to keep the organs safe, eliminating the use of organ transport cooler boxes. For instance, TransMedics Group, Inc. has launched its organ care system, which allows the beating donor heart to be maintained in a warm (34°C) perfused oxygenated state during the transfer from donor to recipient hospitals. This allows for an extended “out of body” time and minimizes the detrimental effects of cold ischemic storage. Moreover, technological advancements in organ care products and the high adoption rate among healthcare professionals due to the increase in reliability, convenience, and portability drive the organ care products market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America organ care products market. The North America organ care products market is expected to grow at a good CAGR during the forecast period.
North America Organ Care Products Market Segmentation
The North America organ care products market is segmented into modality, organ type, end user, and country. Based on modality, the market is segmented into trolley and portable. In 2021, the trolley segment held a larger share of the market. In terms of organ type, the market is segmented into kidney, liver, heart, lungs, and others. In 2021, the kidney segment held the largest market share. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and others. In 2021, the hospitals segment held the largest share of the market. Based on country, the North America organ care products market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2021.
Accord Healthcare; Bridge to Life Ltd; Dr. Franz Koehler Chemie GmbH; Organ Recovery Systems; OrganOx Limited; Paragonix Technologies, Inc; Preservation Solutions, Inc.; TransMedics; Waters Medical Systems LLC; and XVIVO Perfusion are among the leading companies in the North America organ care products market.